| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE | 7 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE | 7 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | DRUG FACTS | 1 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | DRUG FACTS | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | Drug Facts | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | Drug Facts | 2 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 1995 | 1 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules, USP For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules, USP For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | Lansoprazole Delayed-Release Capsules USP, 15 mg | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | Lansoprazole Delayed-Release Capsules USP, 15 mg | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 1995 | 4 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 1995 | 4 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules and Lansoprazole Delayed-Release Orally Disintegrating Tablets safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules Lansoprazole Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules and Lansoprazole Delayed-Release Orally Disintegrating Tablets safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules Lansoprazole Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 2 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 1 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 1995 | 1 | |
| Lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules For oral administration Initial U.S. Approval: 1995 | 1 | |
| Lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules For oral administration Initial U.S. Approval: 1995 | 1 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | PREVPAC ® (lansoprazole 30 mg capsules, amoxicillin 500 mg capsules, USP, and clarithromycin 500 mg tablets, USP) | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVPAC ® (lansoprazole 30 mg capsules, amoxicillin 500 mg capsules, USP, and clarithromycin 500 mg tablets, USP) | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 2 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3956 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3956 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK] | 1000 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK] | 1000 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 28 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 28 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 24 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 24 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [DR.REDDY'S LABORATORIES LTD.] | 18 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [DR.REDDY'S LABORATORIES LTD.] | 18 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN KIT [SANDOZ INC] | 15 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN KIT [SANDOZ INC] | 15 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [MYLAN PHARMACEUTICALS INC.] | 11 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [MYLAN PHARMACEUTICALS INC.] | 11 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SANDOZ INC] | 9 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SANDOZ INC] | 9 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BEST CHOICE (VALU MERCHANDISERS COMPANY)] | 7 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BEST CHOICE (VALU MERCHANDISERS COMPANY)] | 7 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [CHAIN DRUG CONSORTIUM, LLC] | 7 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [CHAIN DRUG CONSORTIUM, LLC] | 7 | |
| Lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED] | 7 | |
| Lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED] | 7 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVACID 24 HR (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [NOVARTIS CONSUMER HEALTH, INC.] | 7 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | PREVACID 24 HR (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [NOVARTIS CONSUMER HEALTH, INC.] | 7 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | PREVPAC (LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 7 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVPAC (LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 7 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SUN PHARMA GLOBAL FZE] | 6 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SUN PHARMA GLOBAL FZE] | 6 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [AMERICAN HEALTH PACKAGING] | 6 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [AMERICAN HEALTH PACKAGING] | 6 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [MYLAN INSTITUTIONAL INC.] | 5 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [MYLAN INSTITUTIONAL INC.] | 5 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN KIT [TEVA PHARMACEUTICALS USA INC] | 5 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN KIT [TEVA PHARMACEUTICALS USA INC] | 5 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [CARDINAL HEALTH] | 5 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | PREVACID (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [CARDINAL HEALTH] | 5 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [MAJOR PHARMACEUTICALS] | 4 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [MAJOR PHARMACEUTICALS] | 4 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [WESTERN FAMILY FOODS, INC.] | 4 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [WESTERN FAMILY FOODS, INC.] | 4 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | BERKLEY AND JENSEN LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [BJWC] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | BERKLEY AND JENSEN LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [BJWC] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | EQUALINE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [SUPERVALU INC] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | EQUALINE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [SUPERVALU INC] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE (LANSOPRAZOLE ) CAPSULE, DELAYED RELEASE [ACTAVIS INC] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE (LANSOPRAZOLE ) CAPSULE, DELAYED RELEASE [ACTAVIS INC] | 3 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [CVS PHARMACY] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [CVS PHARMACY] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [FREDS INC] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [FREDS INC] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [KROGER COMPANY] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [KROGER COMPANY] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [P AND L DEVELOPMENT OF NEW YORK CORPORATION] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [P AND L DEVELOPMENT OF NEW YORK CORPORATION] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [WOCKHARDT USA LLC.] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [WOCKHARDT USA LLC.] | 3 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | UP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | UP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION] | 3 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | CAREONE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AMERICAN SALES COMPANY] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | CAREONE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AMERICAN SALES COMPANY] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | DG HEALTH LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [DOLGENCORP, LLC] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | DG HEALTH LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [DOLGENCORP, LLC] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | GOOD NEIGHBOR PHARMACY LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AMERISOURCE BERGEN] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | GOOD NEIGHBOR PHARMACY LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AMERISOURCE BERGEN] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | GOOD SENSE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [L. PERRIGO COMPANY] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | GOOD SENSE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [L. PERRIGO COMPANY] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | HEALTH MART LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [MCKESSON] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | HEALTH MART LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [MCKESSON] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | HEALTHY ACCENTS LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [DZA BRANDS LLC] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | HEALTHY ACCENTS LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [DZA BRANDS LLC] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | KIRKLAND SIGNATURE LANSOPRAZOLE DELAYED RELEASE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [COSTCO WHOLESALE COMPANY] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | KIRKLAND SIGNATURE LANSOPRAZOLE DELAYED RELEASE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [COSTCO WHOLESALE COMPANY] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AVKARE, INC.] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AVKARE, INC.] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [H E B] | 2 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [H E B] | 2 | |